Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-11-21 5:28 pm Purchase | 13G | GALERA THERAPEUTICS INC GRTX | Novartis Bioventures Ltd | 3,543,067 14.5% | 3,543,067 (New Position) | View |
| 2019-06-07 4:15 pm Sale | 13D | AERPIO PHARMACEUTICALS INC ARPO | Novartis Bioventures Ltd | 3,585,840 8.83% | -463,964 (-11.46%) | View |
| 2019-04-29 08:31 am Sale | 13D | AERPIO PHARMACEUTICALS INC ARPO | Novartis Bioventures Ltd | 4,049,804 9.98% | -869,997 (-17.68%) | View |